Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Whitbourn

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Impact of baseline systolic blood pressure on blood pressure changes following renal denervationRoland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 18, 2013
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trialBernard Chevalier, Carlo Dimario, Franz-Josef Neumann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2016
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trialsJosé de Ribamar Costa, Alexandre Abizaid, Antonio L Bartorelli, et al.
JACC. Cardiovascular Interventions|September 24, 2013
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries)John Ormiston, Mark Webster, James Stewart, et al.
JACC. Cardiovascular Interventions|January 26, 2013
Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosisAndy S Yong, Jamie Layland, William F Fearon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular ScaffoldJosé De Ribamar Costa, Alexandre Abizaid, Antonio L Bartorelli, et al.
Circulation. Cardiovascular Interventions|June 13, 2013
Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarctionJamie Layland, David Carrick, Margaret McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I TrialIan T Meredith, John Ormiston, Robert Whitbourn, et al.
JACC. Advances|February 22, 2025
Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial ProgramFelix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
International Journal of Cardiology|June 23, 2005
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-upAndrew J Boyle, Robert Whitbourn, Stephen Schlicht, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Impact of baseline systolic blood pressure on blood pressure changes following renal denervationRoland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 18, 2013
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trialBernard Chevalier, Carlo Dimario, Franz-Josef Neumann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2016
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trialsJosé de Ribamar Costa, Alexandre Abizaid, Antonio L Bartorelli, et al.
JACC. Cardiovascular Interventions|September 24, 2013
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries)John Ormiston, Mark Webster, James Stewart, et al.
JACC. Cardiovascular Interventions|January 26, 2013
Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosisAndy S Yong, Jamie Layland, William F Fearon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular ScaffoldJosé De Ribamar Costa, Alexandre Abizaid, Antonio L Bartorelli, et al.
Circulation. Cardiovascular Interventions|June 13, 2013
Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarctionJamie Layland, David Carrick, Margaret McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I TrialIan T Meredith, John Ormiston, Robert Whitbourn, et al.
JACC. Advances|February 22, 2025
Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial ProgramFelix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
International Journal of Cardiology|June 23, 2005
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-upAndrew J Boyle, Robert Whitbourn, Stephen Schlicht, et al.
Pageof 10